Corona virus myocarditis in pediatric age group: a rare manifestation of pandemic
DOI:
https://doi.org/10.18203/2349-3291.ijcp20212889Keywords:
Myocarditis, Corona virus, Favipiravir, CorticosteroidsAbstract
Myocarditis is an uncommon disease of adult and pediatric age group, characterized by inflammatory cell infiltrates, myocyte necrosis, or myocyte degeneration due to a myriad of causes and resulting in variable degrees of myocardial dysfunction. Which may be caused by infections, connective tissue disorders, granulomatous diseases, toxic agents or can be idiopathic. Viral infections are the most common etiology accounting for more than 50-60% of cases, particularly enterovirus (Coxsackie virus) and adenovirus groups. The disease is typically sporadic but may be epidemic. Manifestations of myocarditis range from asymptomatic or nonspecific generalized illness to acute cardiogenic shock and sudden death. In our case 10-year-old boy presented with history of fever and cough of 2 days duration. On examination patient found to be having tachycardia and tachypnea without other signs of heart failure. chest x-ray suggestive of bilateral pneumonia, ECG showed features of Myocarditis without any echocardiographic or cardiac enzyme abnormality. Child tested positive for corona virus rapid antigen test. Started on Favipiravir, corticosteroids and managed symptomatically. Child's heart rate normalized over a period of 4 days. Patient subsequently discharged with the advice of follow up echocardiography.
References
Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connell J et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation. 1996;93:841-42.
Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and treatment. Circulation. 2006;113:876-90.
Cooper LT Jr. Myocarditis. N Engl J Med. 2009;360:1526-38.
Schultheiss HP, Kühl U, Cooper LT. The management of myocarditis. Eur Heart J. 2011;32:2616-25.
Kühl U, Schultheiss H-P. Myocarditis in children. Heart Fail Clin. 2010;6:483-96.
Levine MC, Klugman D, Teach SJ. Update on myocarditis in children. Curr Opin Pediatr. 2010;22:278-83.
Foerster SR, Canter CE. Contemporary etiology, outcomes, and therapy in pediatric myocarditis. Prog Pediatr Cardiol. 2011;31:123-8.
Galazka A. The changing epidemiology of diphtheria in the vaccine era. J Infect Dis. 2000;181(1):S2-9.
Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D et al. Contemporary definitions and classifications of the cardiomyopathies. Circulation. 2006;113:1807-16.
Grimaud M, Starck J, Levy M. Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children. Ann Intensive Care. 2020;10(1):69.
Tissières P, Teboul, J. SARS-CoV-2 post-infective myocarditis: the tip of COVID-19 immune complications? Ann Intensive Care. 2020; 10(1).
Belhadjer Z, Méot M, Bajolle F, Khraiche D, Legendre A, Abakka S et al. Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic. Circulation. 2020;142(5):429-36.
Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020; 395(20):1607-08.
Whittaker E, Bamford A, Kenny J, Kaforou M, Jones C, Shah P et al. Clinical Characteristics of 58 Children with a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. JAMA. 2020; 324(3):259-69.
Ramcharan T, Nolan O, Lai C, Prabhu N, Krishnamurthy R, Richter A et al. Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital. Pediatr Cardiol. 2020;41(7):1391-401.
Borocco C, Pouletty M, Galeotti C, Meinzer U, Faye A, Koné-Paut I et al. Response to ‘Correspondence on ‘Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID19): a multicentre cohort. Ann Rheum Dis. 2020;0:1-8.
Buja L, Wolf D, Zhao B, Akkanti B, McDonald M, Lelenwa L et al. The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities. Cardiovascular Path. 2020;48.
Zuo Y, Yalavarthi S, Shi H, Gockman K, Zuo M, Madison J. Neutrophil extracellular traps in COVID-19. JCI Insight. 2020;5(11):1-12.
Elamm C, Fairweather D, Cooper LT. Pathogenesis and diagnosis of myocarditis. Heart. 2012;98:835-40.
Foerster SR, Canter CE. Contemporary etiology, outcomes, and therapy in pediatric myocarditis. Prog Pediatr Cardiol. 2011;31:123-8.
Felker GM, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Baughman KL, Hare JM. Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol. 2000;36:227-32.
Bejiqi R, Retkoceri R, Maloku A, Mustafa A, Bejiqi H, Bejiqi R. The Diagnostic and Clinical Approach to Pediatric Myocarditis: A Review of the Current Literature. Open Access Maced J Med Sci. 2019;7(1):162-73.
Tunuguntla H, Jeewa A, Denfield S. Acute Myocarditis and Pericarditis in Children. Pediatrics in Review. 2019;40(1):14-25.
